RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
BioNexus Gene Lab Stock

BioNexus Gene Lab ROA 2025

BioNexus Gene Lab ROA

-0.16

Ticker

BGLC

ISIN

US0906283066

In 2025, BioNexus Gene Lab's return on assets (ROA) was -0.16, a -33.08% increase from the -0.24 ROA in the previous year.

BioNexus Gene Lab Aktienanalyse

What does BioNexus Gene Lab do?

BioNexus Gene Lab ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding BioNexus Gene Lab's Return on Assets (ROA)

BioNexus Gene Lab's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing BioNexus Gene Lab's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider BioNexus Gene Lab's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in BioNexus Gene Lab’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about BioNexus Gene Lab stock

What is the Return on Assets (ROA) of BioNexus Gene Lab this year?

The Return on Assets (ROA) of BioNexus Gene Lab is -0.16 undefined this year.

What was the ROA of BioNexus Gene Lab compared to the previous year?

The ROA of BioNexus Gene Lab has increased by -33.08% compared to the previous year.

What consequences do high ROA have for investors of BioNexus Gene Lab?

A high ROA is advantageous for investors of BioNexus Gene Lab, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in BioNexus Gene Lab?

A low ROA can be unfavorable for investors of BioNexus Gene Lab as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of BioNexus Gene Lab affect the company?

An increase in ROA of BioNexus Gene Lab can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of BioNexus Gene Lab impact the company?

A reduction in the ROA of BioNexus Gene Lab can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of BioNexus Gene Lab?

Some factors that can influence the ROA of BioNexus Gene Lab include revenue, operating costs, asset structure, and industry average.

Why is the ROA of BioNexus Gene Lab important for investors?

The ROA of BioNexus Gene Lab is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can BioNexus Gene Lab take to improve ROA?

To improve ROA, BioNexus Gene Lab can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does BioNexus Gene Lab pay?

Over the past 12 months, BioNexus Gene Lab paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioNexus Gene Lab is expected to pay a dividend of 0 USD.

What is the dividend yield of BioNexus Gene Lab?

The current dividend yield of BioNexus Gene Lab is .

When does BioNexus Gene Lab pay dividends?

BioNexus Gene Lab pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BioNexus Gene Lab?

BioNexus Gene Lab paid dividends every year for the past 0 years.

What is the dividend of BioNexus Gene Lab?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BioNexus Gene Lab located?

BioNexus Gene Lab is assigned to the '-' sector.

Wann musste ich die Aktien von BioNexus Gene Lab kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BioNexus Gene Lab from 10/23/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/23/2025.

When did BioNexus Gene Lab pay the last dividend?

The last dividend was paid out on 10/23/2025.

What was the dividend of BioNexus Gene Lab in the year 2024?

In the year 2024, BioNexus Gene Lab distributed 0 USD as dividends.

In which currency does BioNexus Gene Lab pay out the dividend?

The dividends of BioNexus Gene Lab are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von BioNexus Gene Lab

Our stock analysis for BioNexus Gene Lab Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioNexus Gene Lab Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.